GlassScriptPhysician profile
Misty N Lee
NPI 1255503413
$19,006.73
in general payments reported to CMS, 2019-2025
37 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $819 · 2021: $526 · 2022: $2,794 · 2023: $487 · 2024: $1,109 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $12K · Food and Beverage: $1,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $12,000.00 |
| Food and Beverage | $1,951.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $12,058.15 | 2023-2025 | |
| Peerless Surgical INC. | $2,044.99 | 2022-2025 | |
| Organogenesis INC. | $1,096.93 | 2019-2023 | Puraply |
| Kerecis Limited | $997.42 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Musculoskeletal Transplant Foundation INC. | $442.19 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $295.58 | 2021-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $209.24 | 2022-2025 | |
| Averitas Pharma INC. | $190.88 | 2023-2025 | Qutenza |
| Abbvie INC. | $141.30 | 2021-2024 | |
| Amgen INC. | $139.78 | 2024 | Krystexxa |
| Grt US Holding, INC. | $138.12 | 2022 | |
| Stability Biologics, LLC | $125.00 | 2024 | |
| Bioventus LLC | $109.68 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Melinta Therapeutics, LLC | $108.32 | 2019 | |
| Bone Support INC. | $101.18 | 2024 | Ceramentbone Void Filler, Cerament G |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $94.29 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Smith+Nephew, INC. | $90.00 | 2019-2022 | |
| Horizon Therapeutics Plc | $87.00 | 2019-2023 | Krystexxa |
| Integra Lifesciences Corporation | $74.48 | 2020-2022 | |
| Nevro Corp. | $58.01 | 2021-2024 | Senza |
| Kci USA, INC. | $45.21 | 2019 | |
| Stryker Corporation | $37.76 | 2022 | |
| Wright Medical Technology, INC. | $33.28 | 2020 | |
| Nabriva Therapeutics, Plc | $31.09 | 2022 | |
| Paragon 28, INC. | $30.12 | 2024 | Bun-Yo-Matic |
| Degen Medical, INC. | $29.29 | 2024 | |
| Zyla Life Sciences, INC. | $29.18 | 2020 | |
| Linvatec Corporation | $24.37 | 2024 | Biobrace 23mm, Colink 2, Allograft Tissue |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.00 | 2021 | |
| Ani Pharmaceuticals, INC. | $19.05 | 2025 | Purified Cortrophin Gel |
| Globus Medical, INC. | $17.99 | 2025 | Senza |
| Kuros Biosciences USA, INC | $16.89 | 2023 | |
| Innovation Technologies INC | $15.83 | 2025 | Irrisept |
| Allergan, INC. | $14.71 | 2020 | |
| Biotissue Holdings INC. | $14.44 | 2023 | |
| Medline Industries LP | $11.72 | 2019 | |
| Cashflow Solutions, LLC | $11.26 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.